Published: Fri, May 19, 2017
Money | By Armando Alvarado

CVS Health Corp (CVS) Shares Sold by Anderson Hoagland & Co

The institutional investor owned 26,696 shares of the pharmacy operator's stock after selling 4,480 shares during the period.

CVS Health Corp (NYSE:CVS)'s stock had its "outperform" rating reiterated by Evercore ISI in a research note issued to investors on Wednesday, May 3rd.

Other hedge funds have also recently modified their holdings of the company. Kernodle & Katon Asset Management Group LLC boosted its position in CVS Health Corp by 842.3% in the first quarter. Independent Investors Inc. boosted its stake in shares of CVS Health Corp by 0.3% in the third quarter. State Street Corp now owns 44,288,047 shares of the pharmacy operator's stock worth $3,494,770,000 after buying an additional 838,787 shares during the last quarter. CVS Health Corp has a 12-month low of $69.30 and a 12-month high of $104.85.

Krensavage Asset Management Llc holds 9.05% of its portfolio in Sucampo Pharmaceuticals, Inc. for 1.86 million shares. Finally, Elgethun Capital Management purchased a new position in shares of CVS Health Corp during the fourth quarter worth approximately $133,000. Beta value of the stock is marked at 0.93. Peloton Wealth Strategists reported 1.79% of its portfolio in CVS Health Corp (NYSE:CVS). Alpha Windward LLC now owns 3,302 shares of the pharmacy operator's stock worth $259,000 after buying an additional 49 shares during the period. 6,029 CVS Health Corp (NYSE:CVS) shares with value of $479,908 were sold by Boratto Eva C. On Thursday, February 16 Roberts Jonathan C sold $4.90 million worth of CVS Health Corp (NYSE:CVS) or 61,196 shares. CVS Health Corp accounts for 1.1% of Regentatlantic Capital LLC's portfolio, making the stock its 19th largest position.

The company reported an impressive total revenue of 177.53 Billion in the last fiscal year. The company has a 50-day moving average price of $79.49 and a 200-day moving average price of $79.46.

CVS Health Corp (NYSE:CVS) last announced its quarterly earnings data on Tuesday, May 2nd. However the company reported $1.32 earnings per share for the same quarter during past year.

Analysts At Loop Capital Indicated Sysco Corporation (NYSE:SYY) As Buy
The investment professionals in our partner's database now have: 402.13 million shares, down from 411.64 million shares in 2016Q3. Parnassus Investments Ca invested in 2.6% or 9.50 million shares. ( NYSE:C ), 15 have Buy rating, 3 Sell and 12 Hold.

CVS Health Corporation (CVS) ended its last session at $79.12 by Declining -1.68%. Comparatively, the peers have a net margin 2.68%, and the sector's average is -2.83%. 76,494 shares valued at $5.99M were sold by MERLO LARRY J on Wednesday, February 1. CVS Health Corporation has far performed well this year, with the share price up 3.25% since January. Analysts on average have given a price target of $86.77 to CVS Health Corporation stock.

The firm also recently declared a quarterly dividend, which was paid on Monday, May 1st. The dividend yield of 6.70% measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The rating was upgraded by Mizuho to "Buy" on Wednesday, April 20.

Thrivent Financial For Lutherans decreased Cvs Health Corp (CVS) stake by 8.99% reported in 2016Q4 SEC filing. If you are reading this piece on another domain, it was illegally copied and reposted in violation of USA and global copyright & trademark law. If you are accessing this piece on another domain, it was stolen and republished in violation of United States and worldwide copyright laws. The legal version of this report can be read at [[permalink]]. Leerink Swann set a $90.00 target price on CVS Health Corp and gave the stock a "buy" rating in a research note on Saturday, March 18th. Bank of America Corp reiterated a "buy" rating and issued a $106.67 price target on shares of CVS Health Corp in a report on Tuesday, February 28th. Atlantic Securities lowered shares of CVS Health Corp from an "overweight" rating to a "neutral" rating and set a $84.00 price target for the a research report on Monday, February 6th.

The company's expected revenue in the current quarter to be 45.39 Billion, seeing a projected current quarter growth of -0.8%, and per annum growth estimates over the next 5 year period of around 7.89%. The stock has "Hold" rating by Deutsche Bank on Thursday, August 20. The mean target of $88.00 should be compared with the price when the stock was languishing around $68.44 a share. Also, EVP Troyen A. Brennan sold 23,849 shares of CVS Health Corp stock in a transaction on Tuesday, March 21st. A P/B ratio of less than 1.0 can indicate that a stock is undervalued, while a ratio of greater than 1.0 may indicate that a stock is overvalued. Following the completion of the transaction, the executive vice president now directly owns 94,309 shares of the company's stock, valued at $7,424,947.57. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Chilton Investment Company Llc holds 0.01% or 3,734 shares. The disclosure for this sale can be found here. Insiders have sold a total of 200,796 shares of company stock worth $16,101,642 in the last three months.

The integrated pharmacy-healthcare company kicked off the campaign with a video sharing hashtag on Twitter and Instagram where women can share advice. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare's long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.

Like this: